mgi mgi tech chinese biotechnology provides line products technologies serves genetic sequencing genotyping gene expression proteomics markets headquarters located shenzhen china mgi founded subsidiary bgi manufactures highthroughput genetic sequencing systems products use life sciences health care july companys operation divided two primary business segments genetic sequencers laboratory automation mgi subsidiary bgi group spun listed shanghai stock exchange may mgi raised billion series b funding idg capital cpe china december company submitted ipo application shanghai stock exchange star september company approval ipo shanghai stock exchange star market hightech march complete genomics acquired bgi acquisition complete genomics moved san jose june became part acquisition one outcomes billion collaborative funds ie years loan initially provided china development bank acquire illumina incs newest fastest nextgeneration sequencers including hiseq company known manufacturing dna sequencers based lowcost dna nanoball sequencing refined parent company bgi acquisition complete genomics refinement included combinatorial probe anchor synthesis technologies involves loading dna nanoballs dnbs onto patterned array chip using fluidic system subsequently sequencing primer added adaptor region dnbs order hybridize human exome sequencing dna enrichment kits based hybridization crna cdna biotinylated probes compatible mgi sequencers utilized specific activities exome viral rna sequencing analysis delta variant guangzhou china two sets sequencing libraries enriched using ampliconbased hybrid capturebased approaches stated research article published eclinicalmedicine lancet discovery science journal assessment variation performed using multipcr data based amplicon sequencing mgis atoplex rna library prep ncov variant detection process data based hybrid capture however mutation sites sequencing depth greater october chairman senate finance committee chuck grassley senator marco rubio wrote joint letter alex azar secretary department health human services seema verma administrator centers medicare medicaid services raised concerns mgi regarding circumstances cms may finance process american citizens genomic exome november federal jury california concluded mgi america capacity affiliate bgi group infringed illumina incs patents accordingly awarded illumina damages march illumina persuaded us district judge prolong restriction mgi america selling coolmps sequencers united states six months august illuminas patent mgis coolmps sequencing chemistry sequencer became commercially available us starting aug complete genomics research subsidiary mgi filed lawsuit may alleging illuminas twochannel dna sequencing chemistry violates two patents technology deduces identification nucleotide two signals novaseq nextseq series well miniseq focus lawsuit illumina additionally targeted illuminas cluster generation sequencing library preparation kits interoperable one may jury delaware concluded illuminas twochannel sequencing chemistry infringes two patents owned mgi tech subsidiary complete genomics result finding jury awarded million damages company jury also dismissed illuminas assertions patents invalid verdict also invalidated three illuminas patents firm asserted countersuit claiming mgi tech infringed illuminas